IL-27 delivered enterically by engineered food bacteria was shown to have therapeutic efficacy in mouse models of IBD (14, 15), and treatment was associated with induction of phosphorylation of STAT1 (pSTAT1) in intestinal tissues (15). This evidence concerns the gene IL27 and inflammatory bowel disease.